ONCY – oncolytics biotech inc. - common shares (US:NASDAQ)

News

UPDATE -- The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
Oncolytics Biotech (ONCY) Loses 8.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]
Oncolytics Biotech (NASDAQ:ONCY) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Oncolytics Biotech® Provides Update on Special Meeting of Shareholders
All You Need to Know About Oncolytics Biotech (ONCY) Rating Upgrade to Buy [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com